Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations and Comprehensive Loss

v3.3.1.900
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
9 Months Ended 12 Months Ended
Dec. 31, 2014
Dec. 31, 2015
Operating expenses    
Research and development $ 1,101,820 $ 1,489,483
General and administrative 1,192,244 2,666,669
Share-based compensation expense (Notes 8(v) and 9) 112,573 1,709,230
Depreciation (Note 5) 34,036 59,479
Total operating expenses 2,440,673 5,924,861
Other expenses (income)    
Imputed interest expense (Note 6) 27,677 0
Interest expense 6,212 3,018
Other income (46,026) (33,974)
Foreign exchange loss 36,211 184,125
Change in fair value of warrant derivative liability (Note 10) 0 (484,124)
Total other (income) expenses 24,074 (330,955)
Net loss for the period (2,464,747) (5,593,906)
Foreign exchange translation adjustment (24,390) 24,799
Net loss and comprehensive loss for the period $ (2,489,137) $ (5,569,107)
Loss per share - basic and diluted (in dollars per share) $ (0.05) $ (0.08)
Weighted average number of shares outstanding - basic and diluted (in shares) 48,225,034 67,210,266